<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5738A2EF-7F57-4DCD-8566-486AD53C00F7"><gtr:id>5738A2EF-7F57-4DCD-8566-486AD53C00F7</gtr:id><gtr:firstName>Bernard</gtr:firstName><gtr:surname>Croal</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C319E5E3-B97E-4835-9B16-09B6FFE6D1F4"><gtr:id>C319E5E3-B97E-4835-9B16-09B6FFE6D1F4</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Andrews</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6483E545-9B97-4463-9018-09A83ADF437A"><gtr:id>6483E545-9B97-4463-9018-09A83ADF437A</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Avenell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/26310B71-5108-4FEA-8F7D-AA05CA2A0FA3"><gtr:id>26310B71-5108-4FEA-8F7D-AA05CA2A0FA3</gtr:id><gtr:firstName>Marion</gtr:firstName><gtr:otherNames>K</gtr:otherNames><gtr:surname>Campbell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0041B58E-F0B2-42B0-BDA8-0EADA7A73349"><gtr:id>0041B58E-F0B2-42B0-BDA8-0EADA7A73349</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>Gordon</gtr:otherNames><gtr:surname>Simpson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/864ECF38-DD70-4DE6-8537-C0E21779B1E4"><gtr:id>864ECF38-DD70-4DE6-8537-C0E21779B1E4</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Noble</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/488FC86F-BFA0-4AEE-ADAA-3F0A6B4D18BE"><gtr:id>488FC86F-BFA0-4AEE-ADAA-3F0A6B4D18BE</gtr:id><gtr:firstName>Luke</gtr:firstName><gtr:surname>Vale</gtr:surname><gtr:orcidId>0000-0001-8574-8429</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0804A81E-2AA5-404A-BAD4-4E89F966D349"><gtr:id>0804A81E-2AA5-404A-BAD4-4E89F966D349</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:surname>MacKirdy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401633"><gtr:id>5BA26EF6-8ACC-4CE7-977C-F78D5BEB8D0A</gtr:id><gtr:title>SIGNET2 - Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401633</gtr:grantReference><gtr:abstractText>The demand for Intensive Care Unit beds is high. Patients in Intensive Care are often very ill, many develop infections and some do not survive. 
In Intensive Care, patients sometimes are given food through a drip into their veins. Previous studies have shown that using specific additives in the food may help patients recover from Intensive Care.
This study is looking at the effect of adding two food supplements called glutamine and selenium to the food given to patients in Intensive Care. The aim of the study is to discover whether patients get fewer infections and to see if this improves chances of survival. 
The study is called a randomised controlled trial. This is the best way to see if a specific treatment really works. Patients are allocated randomly to one of the 4 treatment groups. One group will receive glutamine to the food, one group will receive selenium, one group will receive both and another group will receive the standard food. 
Patients will receive the study food for up to 7 days and will be followed up by postal questionnaires at three and six months. The study will look at the effect on quality of life after Intensive Care and also look at the costs of the new treatments on recovery.</gtr:abstractText><gtr:technicalSummary>The mortality and rate of infective complications in intensive care units (ICUs) is high, and demand for beds exceeds supply. The cost per ICU bed-day exceeds #1330 based on a mean for England and Wales. Approximately 23% of these patients receive parenteral nutrition. The amino acid glutamine and the trace element selenium are absent or in low amounts in standard parenteral formulae. Intravenous supplementation with glutamine or selenium appears to improve outcome in small clinical trials. We have initiated and fully piloted a multicentre, pragmatic, double-blind, randomised controlled trial (with factorial design) which will examine the effects of supplementation with these two comparatively inexpensive constituents on new infections, mortality, morbidity, length of ICU and hospital stay, quality of life and will include an economic analysis. We now request funding for the full trial.</gtr:technicalSummary><gtr:fund><gtr:end>2009-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1006884</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Health Services Research Unit</gtr:department><gtr:description>Health Services Research Unit Aberdeen, Health Economic Unit Aberdeen &amp;amp; University of Edinburgh</gtr:description><gtr:id>C750F5B9-59A4-4590-8CA2-CCD0618B976C</gtr:id><gtr:impact>Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery. Avenell A.
Proc Nutr Soc. 2009 Aug;68(3):261-8. Epub 2009 Jun 3. Review.
PMID: 19490739 [PubMed - indexed for MEDLINE]

Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Crowther M, Avenell A, Culligan DJ.
Bone Marrow Transplant. 2009 Oct;44(7):413-25. Epub 2009 Mar 9. Review.
PMID: 19270730 [PubMed - indexed for MEDLINE]

Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial). Andrews PJ, Avenell A, Noble DW, Campbell MK, Battison CG, Croal BL, Simpson WG, Norrie J, Vale LD, Cook J, de Verteuil R, Milne AC; Trials Management Group.
Trials. 2007 Sep 20;8:25. PMID: 17883854 [PubMed]

Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials.
Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC.
Am J Gastroenterol. 2007 Feb;102(2):412-29; quiz 468. Review. PMID: 17311654 [PubMed - indexed for MEDLINE

Glutamine in critical care: current evidence from systematic reviews. Avenell A.
Proc Nutr Soc. 2006 Aug;65(3):236-41. Review. PMID: 16923308 [PubMed - indexed for MEDLINE]

Glutamine-containing parenteral nutrition: Another piece in the jigsaw? Noble DW, Avenell A.
Crit Care Med. 2006 Mar;34(3):893-4. No abstract available. PMID: 16505670 [PubMed - indexed for MEDLINE]

'(More) trials and tribulations': the effect of the EU directive on clinical trials in intensive care and emergency medicine, five years after its implementation. Robinson K, Andrews PJ.
J Med Ethics. 2010 Jun;36(6):322-5. PMID: 20530086 [PubMed - in process]

Selenium and glutamine supplements: where are we heading? A critical care perspective.
Andrews PJ. Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):192-7. Review. PMID: 20040860 [PubMed - indexed for MEDLINE]</gtr:impact><gtr:outcomeId>adyhZrm7JK7-1</gtr:outcomeId><gtr:partnerContribution>Provided Health Service research and Health economic expertise to Critical Care research group</gtr:partnerContribution><gtr:piContribution>Leadership, critical care experience</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>920000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Society of Intensive Care Medicine - Clinical Trials Program/European Society of Intensive Care Medicine</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>European Society of Intensive Care Medicine (ESICM)</gtr:fundingOrg><gtr:id>4737C144-D573-4615-9943-4BF573804410</gtr:id><gtr:outcomeId>NQb8AXkKGm20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Comparison of clinically suspected infection (attending clinician) with rigorous CDC and adjudication committee</gtr:description><gtr:id>D9CBE3DE-C224-4CB3-81AD-BEF26AF4D0D5</gtr:id><gtr:impact>Similar results are obtained when comparing the two assessments of infection. This makes it possible to develop a more pragmatic trial design where infection is an end point.</gtr:impact><gtr:outcomeId>mfp2uYNBrxm</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Assessment of New Infections in critical care</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7D32DF5B-24C0-436A-A7F8-46B7E8A89724</gtr:id><gtr:title>Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d22bd69ad64632e7a81707795f01f"><gtr:id>f42d22bd69ad64632e7a81707795f01f</gtr:id><gtr:otherNames>Andrews PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>JVL2aqtHXGf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEFA23F0-7A81-438A-958E-0694A7108974</gtr:id><gtr:title>Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation.</gtr:title><gtr:parentPublicationTitle>Bone marrow transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d9aad54bc283a980f7c8f2c435f1713"><gtr:id>6d9aad54bc283a980f7c8f2c435f1713</gtr:id><gtr:otherNames>Crowther M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-3369</gtr:issn><gtr:outcomeId>URXnAfsBAg2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20E6EB4B-8E16-442B-934A-65681CF87A03</gtr:id><gtr:title>'(More) trials and tribulations': the effect of the EU directive on clinical trials in intensive care and emergency medicine, five years after its implementation.</gtr:title><gtr:parentPublicationTitle>Journal of medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8daea59cb2444c40ecae21e2ae9d204b"><gtr:id>8daea59cb2444c40ecae21e2ae9d204b</gtr:id><gtr:otherNames>Robinson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0306-6800</gtr:issn><gtr:outcomeId>jFrmYQYWDJG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC07999A-98B3-4E7A-B4CD-951A7A3B0FAF</gtr:id><gtr:title>Selenium and glutamine supplements: where are we heading? A critical care perspective.</gtr:title><gtr:parentPublicationTitle>Current opinion in clinical nutrition and metabolic care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d22bd69ad64632e7a81707795f01f"><gtr:id>f42d22bd69ad64632e7a81707795f01f</gtr:id><gtr:otherNames>Andrews PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1363-1950</gtr:issn><gtr:outcomeId>NyLmt3Bcg7w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36B8B605-2F24-4A6E-8DF0-4361CEB76305</gtr:id><gtr:title>Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d22bd69ad64632e7a81707795f01f"><gtr:id>f42d22bd69ad64632e7a81707795f01f</gtr:id><gtr:otherNames>Andrews PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>sYBaNXL94vy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91B55AB2-6F33-410D-9185-A282E9F24575</gtr:id><gtr:title>Glutamine-containing parenteral nutrition: Another piece in the jigsaw?</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe66773458049ccb6cd4ac41084701d"><gtr:id>fbe66773458049ccb6cd4ac41084701d</gtr:id><gtr:otherNames>Noble DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>VZT6ZuMQa3H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBBB8030-E292-4B44-AEDD-DCFE131D7964</gtr:id><gtr:title>Glutamine in critical care: current evidence from systematic reviews.</gtr:title><gtr:parentPublicationTitle>The Proceedings of the Nutrition Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e18199aad22cd85e8855c1364613709"><gtr:id>6e18199aad22cd85e8855c1364613709</gtr:id><gtr:otherNames>Avenell A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0029-6651</gtr:issn><gtr:outcomeId>kDp1Uhh1EdX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99BD7D49-7317-4F83-AF3F-58D1E9E422EE</gtr:id><gtr:title>Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery.</gtr:title><gtr:parentPublicationTitle>The Proceedings of the Nutrition Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e18199aad22cd85e8855c1364613709"><gtr:id>6e18199aad22cd85e8855c1364613709</gtr:id><gtr:otherNames>Avenell A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0029-6651</gtr:issn><gtr:outcomeId>sHr8UX2jxRi</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401633</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>